Results 231 to 240 of about 59,720 (309)

Dose‐dependent efficacy and safety of centanafadine in patients with attention‐deficit/hyperactivity disorder: A systematic review of the latest evidence

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 4, December 2026.
Abstract Centanafadine is a multimodal norepinephrine–dopamine–serotonin reuptake inhibitor (NDSRI) that has been evaluated for the treatment of attention‐deficit/hyperactivity disorder (ADHD) across pediatric, adolescent, and adult populations. This systematic review aimed to evaluate the efficacy, safety, and tolerability of centanafadine compared ...
Daud Gul   +12 more
wiley   +1 more source

ANGLIYA XX ASR OXIRI XXI ASR BOSHLARIDA

open access: yes
Otaxonova Gulsanam Alisher qizi   +1 more
openaire   +1 more source

Genome‐wide prediction of cloned disease resistance homologues across the Oryza genus

open access: yesThe Plant Genome, Volume 19, Issue 4, December 2026.
Abstract The wild relatives of rice (Oryza sativa L.) represent reservoirs of genetic diversity and potential sources of novel pest and disease resistance. The recent availability of high‐quality Oryza genome assemblies has enabled greater exploration of this diversity across the genus.
Sabrina Morrison   +4 more
wiley   +1 more source

Support‐Driven Hydrogen Migration Enhances Ammonia Decomposition in Direct Ammonia Protonic Ceramic Fuel Cells

open access: yesENERGY &ENVIRONMENTAL MATERIALS, Volume 9, Issue 6, November 2026.
Enhanced hydrogen species migration enabled by FN/BZY catalyst mitigates intermediate accumulation and improves DA‐PCFC performance during ammonia decomposition. Ammonia, with its high hydrogen density and carbon‐free nature, serves as ideal fuel for direct ammonia protonic ceramic fuel cells (DA‐PCFCs).
Meijuan Fei   +9 more
wiley   +1 more source

Acute Caffeine Intake Does Not Modulate Active or Reactive Inhibition in Non‐Clinical Young Adults, and ADHD Symptoms Do Not Moderate Its Effects

open access: yesHuman Psychopharmacology: Clinical and Experimental, Volume 41, Issue 6, November 2026.
ABSTRACT Background Caffeine is consumed for its presumed cognitive benefits, yet controlled studies have repeatedly failed to find effects on inhibitory control. Cross‐sectional work suggests that people with elevated attention‐deficit/hyperactivity disorder (ADHD) symptoms may benefit from chronic, moderate caffeine consumption, but whether acute ...
Ahmet Altınok
wiley   +1 more source

Home - About - Disclaimer - Privacy